Strengthening US Drug Production: Pharmaceutical Supply Chain Security
This act establishes a commission to assess and strengthen the security of the pharmaceutical supply chain in the United States. The goal is to reduce reliance on foreign manufacturers and ensure citizens have access to essential medicines, even in challenging circumstances.
Key points
Establishment of a commission to evaluate vulnerabilities in the domestic pharmaceutical supply chain.
Development of plans to increase the production of key drug ingredients in the US.
Exploring ways to use healthcare programs to support domestic drug manufacturing.
Identifying facilities that can be repurposed for domestic drug production.
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens
(explained here).
Start recording it now.